iRhythm Holdings, Inc. Common Stock (IRTC) — Analysis Summary
iRhythm Holdings, Inc. Common Stock (IRTC) has a market cap of $3.83B with year-over-year revenue growth of +26.2%. Net margin stands at -6.0%. The stock trades at a P/E ratio of -274.9.
Key Takeaways
- Revenue changed +26.2% year-over-year
- Net margin of -6.0%
- P/E ratio of -274.9
Compared to other companies in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector, IRTC posted revenue growth of +26.2% and trades at a P/E of -274.9.
iRhythm Holdings, Inc. Common Stock (IRTC)
UPDATED — ET · MARKET DATA POLYGON · FINANCIALS SEC EDGAR
Red Flags & WarningsHigh Risk Signals
Multiple material red flags are active and deserve closer underwriting before relying on any valuation output.
Interest coverage at -1.9x — earnings do not cover interest payments
D/E at 3.5x — high financial leverage
iRhythm Holdings Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.
Sector
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Employees
2,400
Headquarters
San Francisco, CA
Exchange
XNAS
Systematic competitive advantage assessment based on 4yr data
This assessment is based on quantitative analysis of historical financial data and does not constitute investment advice. Moat ratings may change with industry and competitive dynamics.
First version surfaces recent SEC Forms 3, 4, and 5 activity. It does not yet parse individual buy/sell transactions.
Capital Structure
Cash Flow
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.